SNStephen Naulls

Stephen Naulls

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen Naulls has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ‘Chemsex’ then and now – towards a ‘6Ws’ model for functional analysis and configurational assessment that embraces phenotypic diversity

    by Stephen Naulls

    Background: Distinguishing problematic from non-problematic chemsex, or placing experience on a continuum of severity, generates limited information about why similar drug use can lead to different experiences and support needs. We propose considering how the circumstances of an encounter work together and change over time.Method: This think piece presents a selective conceptual synthesis of chemsex research and assessment approaches, informed by minority stress theory, drug, set and setting, functional analysis, and addiction science. Empirical studies inform the domains and the proposed relationships between them.Results: Six questions (who, what, why, with, where and when) describe the person, substances, functions, relationships, settings and timing within a changing chemsex configuration. Digital activity may connect these through partner contact, planning and support, and is an important emerging consideration. Three fictional vignettes illustrate different responses to comparable exposure. The person and therapist could each map the configuration, compare accounts and identify a focus for formulation and therapy.Conclusions: Assessment should determine how pleasure, protection and harm arise through interacting circumstances. The six Ws direct attention to these relationships and to differences between the person’s and therapist’s accounts. Participatory development and longitudinal evaluation are needed to establish whether this approach improves shared understanding, decisions and care.

  • Open Access

    Neurobiological mechanisms underpinning chemsex: a scoping review of human neuroimaging and neurophysiological studies

    by Stephen Naulls, Jessica Eccles, James Stone

    Background: Chemsex is a subculture of sexualised drug use commonly observed in men who have sex with men. The existing literature largely covers motivations for engagement, harm profiles, and service needs. There is a distinct lack of robust neurobiological evidence.Aims: We mapped direct neuroimaging and neurophysiological evidence on chemsex. We also defined adjacent evidence that could inform reciprocal reinforcement between drug effects and sexual reward.Methods: We searched PubMed for adult human studies published from January 2000 to February 2026. One eligibility framework admitted direct chemsex evidence and drug–sexual convergence within one design. A third route admitted studies of pre-specified chemsex-component processes.Results: We included 26 studies: one direct study, six drug–sexual convergence studies and 19 chemsex component studies. Five concerned GHB/GBL, four concerned methamphetamine and two concerned ketamine. Eleven addressed sexual reward, CSBD or problematic pornography use. Three linked neural measures to sexual risk or control in MSM. The direct chemsex study used EEG. Acute GHB work linked GHB with altered erotic appraisal and nucleus accumbens–ventromedial prefrontal coupling. Methamphetamine and ketamine studies produced task-specific findings without modelling sexualised drug use. Adjacent studies implicated anticipation and conditioning. Other findings concerned insula-linked salience or cognitive control, but several results were null or anatomically narrow.Conclusions: There is a distinct lack of neurobiology-driven chemsex research. This review identifies plausible biological regions of interest and brain networks that may be altered in chemsex as possible targets for future neuroimaging and neurophysiological studies.Keywords: chemsex; sexualised drug use; neuroimaging; EEG; gamma-hydroxybutyrate; methamphetamine; ketamine; compulsive sexual behaviour

  • Open Access

    Lifestyle Medicine in Medical Education: Benefits for Patients, Communities, and Our Future Medical Workforce

    by Stephen Russell Naulls, Anna Ogier, Ana Baptista, Christopher James Harvey, Richard J Pinder

    Lifestyle Medicine (LM) is an increasingly important aspect of modern medical practice. LM focuses on sleep, healthy eating, physical activity, mental wellbeing, and the socioeconomic determinants of health. In 2019, Imperial College London introduced the ‘Lifestyle Medicine and Prevention’ (LMAP) module to educate medical students on these areas within a broader framework of public health ethics and practice. We hypothesised that early LM education may enhance students’ insight into their own health and wellbeing. Of 364 first-year medical students invited to complete an end-of-module survey, 278 consented to share their data and 239 responded to the open-ended question analysed: ‘Has your LMAP learning encouraged you to change any of your health behaviours? Please explain how’. Responses were analysed thematically. Of 239 responses, 155 students (66%) reported changes in their health behaviours after the LMAP module, 57 (24%) reported no change, and 27 (10%) described early contemplation of change. Lifestyle Medicine education may encourage reflection and positive health behaviour change amongst medical students.

  • Open Access

    Sociodemographic and geographical variation in prescribing psychotropic drugs to children and young people with common mental disorders and Attention Deficit Hyperactive Disorders in North West London: population-based study

    by Antonio Ivan Lazzarino, Stephen Russell Naulls, Rinad Bakhti, Steven Hope, Dasha Nicholls, Michaela Otis, Tamsin Robinson, Shamini Gnani, Dougal S Hargreaves

    Objectives: To estimate the sociodemographic and geographical variation in prescribing selective serotonin reuptake inhibitors (SSRIs) and medications for attention-deficit/hyperactivity disorder (ADHD) to children and young people (CYP) in North West London, UK. Design: Cross-sectional population-based study. Setting: General practices in North West London, UK, with data for the period 2020–2022 obtained from the Discover Now platform, which covers approximately 95% of the local population. Participants: 762 390 CYP aged 5–24 years in the year 2022. Primary and secondary outcome measures: Primary outcome: Prescription rates of SSRIs and ADHD medications. Secondary outcomes: Associations between prescription rates and sociodemographic factors, including age, gender, geographical area (local authority), ethnicity and socioeconomic deprivation (measured using the Index of Multiple Deprivation). Results: The total sample comprised 762 390 CYP. 2.20% of the sample were prescribed an SSRI (95% CI 2.17% to 2.24%) and 0.50% an ADHD medication (95% CI 0.49% to 0.52%) in years 2020–2022. High deprivation was associated with the highest rates of an SSRI prescription (2.5%). In contrast, low deprivation was associated with the highest rates of an ADHD medication prescription (0.70%). This divergent pattern was evident in some London boroughs and not in others. The relationship between level of area deprivation and prescription rates also differed by borough. Overall, the sociodemographic factors could not explain most of the variation in prescription rates (Pseudo R 2 0.18 for SSRI and 0.06 for an ADHD medication). Conclusions: Prescriptions for common mental disorders and ADHD for CYP from North West London varied by sociodemographic characteristics and London borough of residence, potentially exacerbating mental health inequalities. To monitor and address these inequalities, more extensive use of linked electronic health records should be undertaken; for example, data on mental health diagnosis and service utilisation are needed to investigate the relationship between diagnosis and treatment over time.

  • Regulation of psychological professionals in mental health care

    by Stephen Naulls, Clare Lally

    Some psychological professionals provide treatments to support mental health. However, regulation varies across different roles. What are the risks and policy considerations?

  • Public health: inequalities and prevention

    by Parliamentary Office of Science and Technology, Stephen Naulls, Sumayyah Mian, Yohanna Sallberg, Natasha Mutebi, Clare Lally

    How can we address growing public health challenges? How can we mitigate health inequalities and ensure fair and timely access to healthcare?

  • Psychedelic-assisted therapy for mental health: Policy considerations

    by Parliamentary Office of Science and Technology, Jenny Chapman, Stephen Naulls

    Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.